REFERENCES
- Bolla M, Collette L, , et al. (2002) Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360:103–108.
- Crawford ED, Eisenberger MA, , et al. (1989) A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 321:419–424.
- Denis LJ, Carneiro de Moura JL, , et al. (members of the EORTC GU Group and EORTC Data Center) (1993) Goserelin acetate and flutamide versus bilateral orchiectomy: a phase III EORTC trial (30853). Urology 42:119–130.
- Fernandez del Moral P, Dijkman GA, , et al. (1996) Three-month depot of goserelin acetate: clinical efficacy and endocrine profile. Dutch south east cooperative urological group. Urology 48:894–900.
- Heyns CF, Simonin MP, , et al. (2003) Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer. BJU Int 92:226–231.
- Japanese Urological Association and Japanese Society of Pathology (2001) General rules for clinical and pathological studies on prostate cancer. Kanehara, Tokyo, pp 72–89.
- Kaisary AV, Tyrrell CJ, , et al. (1991) Comparison of LHRH analogue (Zoladex) with orchiectomy in patients with metastatic prostatic carcinoma. Br J Urol 67:502–508.
- Kuhn JM, Abourachid H, , et al. (1997) A randomized comparison of the clinical and hormonal effects of two GnRH agonists in patients with prostate cancer. Eur Urol 32:397–403.
- Labrie F, Dupont A, , et al. (1984) Simultaneous administration of pure antiandrogens, a combination necessary for the use of luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer. Proc Natl Acad Sci U S A 81:3861–3863.
- Labrie F, Dupont A, , et al. (1987) Flutamide eliminates the risk of disease flare in prostatic cancer patients treated with a luteinizing hormone-releasing hormone agonist. J Urol 138:804–806.
- Messing EM, Manola J, , et al. (1999) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med 341:1781–1788.
- Pilepich MV, Winter K, , et al. (2005) Androgen suppression adjuvant to definitive radiotherapy in carcinomas of the prostate - long term results of phase III RTOG 85–31. Int J Radiat Oncol Biol Phys 61:1285–1290.
- The Leuprolide Study Group (1984) Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med 311:1281–1286.
- Vogelzang NJ, Chodak GW, , et al. (1995) Goserelin versus orchiectomy in the treatment of advanced prostate cancer: final results of a randomized trial. Urology 46:220–226.